 GEFs are potential target for cancer therapy due to their role in many signaling pathways, particularly cell proliferation.For example, many cancers are caused by mutations in the MAPK/ERK pathway that lead to uncontrolled growth.The GEF SOS1 activates Ras, whose target is the kinase Raf.